Our previous studies showed that LRRC4 regulates cytokine-induced NF-κB activation in glioma cells and that LRRC4 regulates the ERK/MAPK and the PI3K/AKT signaling pathway and therefore modulates cell proliferation, migration, and invasion (Li et al. 2014). This evidence concerns the gene AKT1 and central nervous system cancer.